Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FORMA THERAPEUTICS HOLDINGS, INC.

(FMTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

FORMA THERAPEUTICS HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)

06/21/2021 | 05:06pm EDT

Item 5.07 Submission of Matters to a Vote of Security Holders

Forma Therapeutics Holdings, Inc. (the "Company") held its Annual Meeting of Stockholders on June 17, 2021 (the "Annual Meeting"). At the Annual Meeting, the Company's stockholders considered and voted on the two proposals set forth below, each of which is described in greater detail in the Company's Proxy Statement, filed with the Securities and Exchange Commission on April 21, 2021. The final voting results are set forth below.

Proposal 1 - Election of Class I Director Nominees

The stockholders of the Company elected Selwyn M. Vickers, M.D. and Wayne A.I. Frederick, M.D. as Class I directors of the Company, for a three-year term ending at the annual meeting of stockholders to be held in 2024 and until their successor have been duly elected and qualified or until their earlier resignation or removal. The results of the stockholders' vote with respect to the election of the Class I directors were as follows:



                                         Votes           Votes         Broker
         Name                             For          Withheld       Non-Votes
         Selwyn M. Vickers, M.D.        32,867,626       242,988       1,796,704
         Wayne A.I. Frederick, M.D.     32,867,630       242,984       1,796,704

Proposal 2 - Ratification of Appointment of the Company's Independent Registered Public Accounting Firm

The stockholders of the Company ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. The results of the stockholders' vote with respect to such ratification were as follows:



                        Votes       Votes     Votes     Broker
                         For       Against   Abstain   Non-Votes
                      34,904,928    2,035      355         0

No other matters were submitted to or voted on by the Company's stockholders at the Annual Meeting.




                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about FORMA THERAPEUTICS HOLDINGS, INC.
09/17FORMA THERAPEUTICS : to Participate in Upcoming Investor Conferences
BU
08/17FORMA THERAPEUTICS : HC Wainwright Adjusts Price Target on Forma Therapeutics Holdings to ..
MT
08/13FORMA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
08/13FORMA THERAPEUTICS' : Q2 Loss Narrows, Operating Expenses Rise
MT
08/13FORMA THERAPEUTICS HOLDINGS, INC. : Results of Operations and Financial Condition (form 8-..
AQ
08/13FORMA THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Provides Business U..
BU
08/13Forma Therapeutics Holdings, Inc. Reports Unaudited Consolidated Earnings Results for t..
CI
08/13NORTH AMERICAN MORNING BRIEFING : Blockbuster -3-
DJ
08/06FORMA THERAPEUTICS : to Report Second Quarter 2021 Financial Results and Provide Business ..
BU
08/02FORMA THERAPEUTICS : Craig-Hallum Starts Forma Therapeutics Holdings at Buy With $58 Price..
MT
More news
Analyst Recommendations on FORMA THERAPEUTICS HOLDINGS, INC.
More recommendations